The first report from Skills England sets out the key skills challenges that limit growth and opportunity. It also assesses skills needs in the economy.
In this article, Dr. Fawzi Abou-Chahine, Grants Director at FI Group UK, delves into the evolving landscape of grant funding in the biotechnology sector.
RSSL has today announced that it has secured funding from Innovate UK, the UK’s national innovation agency, to establish the country’s first Novel Foods Expert Network for Regulatory Challenges (NFX UK).
Pioneer Group, the life science infrastructure and venture building specialist, has joined forces with Innovate UK, The Medical Research Council (MRC) and AstraZeneca, to deliver the AI in Health Accelerator 2024/2025 Programme.
TechBio's 2024 breakthroughs proved it’s not just innovating—it’s transforming healthcare, with the UK leading the charge into a future where biology, tech, and data redefine possibilities.
The BIA is driving progress across life sciences, from shaping policy in engineering biology and advocating for balanced perspectives in the Covid Inquiry to exhibiting UK innovation at J.P. Morgan Healthcare Week.
The UK’s Cell and Gene Therapy Catapult has published new insights into the advancement of the UK’s cell and gene therapy industry in its 2024 ATMP Clinical Trials Database.
United Kingdom National Nuclear Laboratory and Medicines Discovery Catapult have received funding to drive the development of innovative approaches for new cancer treatments.
As a significant milestone in the University’s history as an apprenticeship provider, Manchester Met’s Laboratory Scientist (Bioscience) Degree Apprenticeship has become the first Level 6 apprenticeship to be accredited by the Royal Society of Biology (RSB).
As we bid a fond farewell to Christiane Abouzeid after over 20 years of outstanding service to the BioIndustry Association, we are also thrilled to announce new leadership changes within our Policy and Public Affairs team.
Chromatin Bioscience is pleased to announce its ongoing collaboration with EsoBiotec, which has successfully advanced its ESO-T01 in vivo CAR-T candidate into clinical trials.
In this blog, Maddie Cass, Senior Policy and Public Affairs Executive at the BIA, shares our perspective on the recent EngBio public trust survey findings conducted by the DSIT.
The International R&D Tax Guide is a comprehensive resource designed to assist businesses in understanding and leveraging R&D tax incentives across various jurisdictions.
